Welcome to our dedicated page for Bio-Key Intl news (Ticker: BKYI), a resource for investors and traders seeking the latest updates and insights on Bio-Key Intl stock.
BIO-key International Inc (BKYI) delivers innovative biometric authentication solutions for enterprise security and identity management. This dedicated news hub provides investors and industry professionals with complete access to official company announcements and verified developments.
Track all critical updates including earnings disclosures, product launches, strategic partnerships, and regulatory filings. Our curated collection ensures efficient monitoring of BKYI's advancements in fingerprint biometrics, identity-as-a-service platforms, and cybersecurity innovations.
Discover updates on key operational areas: deployment of PortalGuard® identity solutions, government sector contracts, and advancements in passwordless authentication technology. Content is rigorously verified to support informed decision-making in the biometrics and cybersecurity markets.
Bookmark this page for streamlined access to BIO-key's latest milestones. Check regularly for authoritative updates on one of the biometric industry's most dynamic providers of hardware and software authentication solutions.
BIO-key International (NASDAQ: BKYI), a provider of Identity and Access Management solutions, reported strong Q2 2025 financial results with revenue increasing 49% to $1.7M. The growth was driven by increases across all segments, with software license fees up 4% to $806K, services revenue rising to $322K, and hardware sales significantly increasing to $569K.
The company launched its BIO-key CyberDefense Initiative to target the growing global defense market, particularly in Europe where EU member states are expected to spend €350B on defense by 2026. Notable Q2 achievements include securing over $600K in follow-on orders from a Foreign Defense Ministry and establishing their first major IAM deployment with a national bank in Mozambique.
Despite the revenue growth, the company reported a net loss of ($1.17M), or ($0.20) per share, though improved from ($1.67M) in Q2'24. Gross margin was 73%, down from 77% year-over-year due to increased hardware sales.
BIO-key International (NASDAQ: BKYI), a provider of Identity and Access Management solutions with biometric authentication capabilities, has scheduled its Q2 2025 earnings conference call for Wednesday, August 13th at 10:00 AM ET. The company will release its financial results before market open on the same day.
The call will be led by Chairman & CEO Mike DePasquale and CFO Cecilia Welch, featuring a Q&A session. Investors can access the call via U.S. dial-in (1-877-418-5460) or international dial-in (1-412-717-9594), with webcast replay available for 3 months.
BIO-key International (NASDAQ: BKYI), a leader in Identity and Access Management (IAM) and biometric authentication solutions, has joined ISMS Forum, Spain's premier cybersecurity association. Through this membership, BIO-key will participate in initiatives focused on identity management, Zero Trust security, and regulatory compliance.
The company will collaborate with ISMS Forum members to shape cybersecurity standards, support compliance with NIS2 and GDPR regulations, and contribute expertise in Identity-Bound Biometrics (IBB), Multi-factor Authentication (MFA), and Single Sign-On (SSO). This strategic move reinforces BIO-key's expanding presence in Spain and commitment to enhancing cybersecurity resilience.
BIO-key International (NASDAQ: BKYI) has announced a strategic partnership with Runlevel, a cybersecurity solutions provider, to expand its Identity and Access Management (IAM) solutions in Portuguese-speaking African countries (PALOP) and Timor-Leste. The partnership has already secured its first major customer - a National Bank in Mozambique, which will implement BIO-key's biometric-based IAM solutions including PortalGuard On-Prem with Multi-factor Authentication and Single Sign-On capabilities.
As part of BIO-key's Channel Alliance Partner program, Runlevel will serve as a Value-Added Reseller, providing pre-sales consulting, deployment support, and technical training tailored to local regulatory requirements. This partnership marks BIO-key's strategic expansion into Portuguese-speaking markets and strengthens its position in the global financial sector.
BIO-key International (Nasdaq: BKYI), a provider of Identity and Access Management (IAM) solutions featuring Identity-Bound Biometric (IBB) authentication, has announced its participation in two upcoming investor presentations. The company will present at the Aegis Capital Virtual Conference on Thursday, May 22, 2025, from 11:30 to 11:55 a.m. ET, and participate in a fireside chat at the Maxim Virtual Tech Conference on Wednesday, June 4, 2025, at 11:00 a.m. ET. The Maxim conference will be hosted on M-Vest, requiring membership registration for access. Investors can submit questions and request management meetings through both events.
BIO-key International (NASDAQ: BKYI) has announced a strategic partnership with Cloud Distribution Co., a Value-Added Distributor based in Saudi Arabia, to expand its Identity and Access Management (IAM) and biometric authentication solutions across the Middle East. Cloud Distribution joins BIO-key's Channel Alliance Partner program and will distribute BIO-key's complete suite of solutions in Saudi Arabia, UAE, and the region.
Cloud Distribution has invested in dedicated resources in Riyadh, including a Pre-Sales Engineer, Business Development Manager, and Project Manager, specifically for BIO-key operations. The partnership will focus on key technologies including PortalGuard IAM platform, Passkey:YOU, PIN:You, WEB-key biometric engine, Identity-Bound Biometrics, and certified biometric scanners.
BIO-key International (NASDAQ: BKYI), a provider of Identity and Access Management solutions featuring Identity-Bound Biometric capabilities, has scheduled its first quarter 2025 earnings conference call for Friday, May 16th at 10:00 AM ET. The company will release its Q1 2025 financial results after market close on Thursday. The conference call will be led by Chairman & CEO Mike DePasquale and CFO Cecilia Welch, followed by a Q&A session.
Investors can access the call via phone at 1-877-418-5460 (U.S.) or 1-412-717-9594 (International). A webcast replay will be available for 3 months, and an audio replay can be accessed using code 6501265.
BIO-key International (NASDAQ: BKYI), a provider of Identity and Access Management solutions, has successfully regained compliance with Nasdaq listing requirements. The company had received a non-compliance notice on April 17, 2025, due to failing to timely file its Annual Report (Form 10-K) for the year ended December 31, 2024, violating Nasdaq Listing Rule 5250(c)(1).
The notification did not immediately affect BKYI's listing status on the Nasdaq Capital Market. The company resolved the issue by filing its Form 10-K on April 23, 2025, and received confirmation of compliance restoration from Nasdaq on April 24, 2025, officially closing the matter.
FAQ
What is the current stock price of Bio-Key Intl (BKYI)?
What is the market cap of Bio-Key Intl (BKYI)?
